ClearGuard HD Antimicrobial Barrier Cap for preventing haemodialysis catheter-related bloodstream infections is a central venous catheter cap with chlorhexidine acetate coated rod and cap threads, used to help prevent catheter-related bloodstream infections in people having haemodialysis.
 
Status In progress
Process MT
ID number 561

Provisional Schedule

Scope published 30 April 2021
Committee meeting: 1 20 August 2021
Draft guidance: 1 13 September 2021 - 11 October 2021
Committee meeting: 2 12 November 2021
Resolution 20 December 2021
Expected publication 02 February 2022

Project Team

Project lead Samantha Baskerville

Email enquiries

Stakeholders

Manufacturers ICU MEDICAL
Others Association of British Healthcare Industries (ABHI)
  Association of Healthcare Technology Providers for Imaging, Radiotherapy and Care (AXrEM)
  Boston Scientific
  Department of Health and Social Care
  Devices for Dignity
  Greater Manchester Health & Social Care Partnership
  Healthcare Improvement Scotland
  HealthTech Alliance
  Johnson & Johnson Medical Ltd
  Medical Technology Group
  Medicines and Healthcare Products Regulatory Agency
  University of Manchester Wounds Research Group
  NHS England
  The British In Vitro Diagnostics Association (BIVDA)

Timeline

Key events during the development of the guidance:

Date Update
17 March 2021 Stakeholder registration opens

For further information on how we develop guidance, please see our page about NICE medical technologies guidance